307 related articles for article (PubMed ID: 1487309)
1. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
3. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
4. Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes.
Hansson J; Dohlsten M; Sjögren HO; Hedlund G
Eur J Immunol; 1995 Jan; 25(1):75-9. PubMed ID: 7843256
[TBL] [Abstract][Full Text] [Related]
5. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
Hansson J; Ericsson PO; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
Int Immunol; 1994 Sep; 6(9):1375-81. PubMed ID: 7819146
[TBL] [Abstract][Full Text] [Related]
6. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes.
Herrmann T; Romero P; Sartoris S; Paiola F; Accolla RS; Maryanski JL; MacDonald HR
J Immunol; 1991 Apr; 146(8):2504-12. PubMed ID: 1707909
[TBL] [Abstract][Full Text] [Related]
8. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
[TBL] [Abstract][Full Text] [Related]
9. Murine CD4+ and CD8+ T cells are activated by the superantigen (SA) staphylococcal enterotoxin B (SEB) and exhibit MHC-unrestricted cytotoxicity.
Miethke T; Bendigs S; Bader P; Wagner H; Heeg K
Zentralbl Bakteriol; 1991 Jun; 275(2):264-8. PubMed ID: 1681814
[TBL] [Abstract][Full Text] [Related]
10. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
12. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
[TBL] [Abstract][Full Text] [Related]
13. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
14. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
[TBL] [Abstract][Full Text] [Related]
15. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
16. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
[TBL] [Abstract][Full Text] [Related]
17. Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.
Hedlund G; Dohlsten M; Petersson C; Kalland T
Cancer Immunol Immunother; 1993; 36(2):89-93. PubMed ID: 8425213
[TBL] [Abstract][Full Text] [Related]
18. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.
Phillips JH; Gumperz JE; Parham P; Lanier LL
Science; 1995 Apr; 268(5209):403-5. PubMed ID: 7716542
[TBL] [Abstract][Full Text] [Related]
19. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal enterotoxin-mediated human T-T cell interactions.
Koning F; Rust C
J Immunol; 1992 Jul; 149(1):317-22. PubMed ID: 1535087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
